CannabisNewsBreaks Archive - Page 395 of 410

WednesdaySep 13, 2017 9:22 am

CannabisNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Enters Letter of Intent with BlazeNow, Inc.

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., has executed a Letter of Intent with BlazeNow, Inc., a majority owned subsidiary of MediaTechnics Corporation (OTC: MEDT). BlazeNow, once called the “Yelp” of the cannabis industry by NY Daily News, is an advertising and data collection platform focused on connecting cannabis-related businesses with patients and customers. “We are excited to lay the groundwork for what we believe will be a very productive business partnership with BlazeNow,” Vanessa Luna, COO of MoneyTrac Technology, stated in the news release. “The goals are…

TuesdaySep 12, 2017 10:23 am

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Records 76% YOY Increase in Revenues for FY2017

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its financial results for the fiscal year ended May 31, 2017. Among the highlights, the company recorded a 76 percent increase in total operating revenues as compared to 2016. CIIX noted that both its investor relations business and its subscription business posted strong growth during the 12-month period, with revenues increasing by 130 percent and 57 percent, respectively. The company also provided an update on its outlook for fiscal year 2018. “Although the business of our Consumer Division is still in the early stages, the recently launched 'OptHemp' product line…

TuesdaySep 12, 2017 9:54 am

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Files Provisional Patent Covering Proprietary Biosynthesis Program

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its filing of a provisional patent application pertaining to the company’s biosynthesis program for the manufacture of cannabinoids that are identical to those found in nature. Per the news release, this patent application, once converted into an international Patent Cooperation Treaty (PCT) application and pursued in key jurisdictions around the world, will offer significant commercial protections for InMed’s promising E. coli-based expression system, which enables the manufacture of any of the 90+ cannabinoid compounds found in the cannabis plant. “This novel approach to the biosynthesis of…

MondaySep 11, 2017 1:11 pm

CannabisNewsBreaks – Tetra Bio-Pharma (TSX.V: TBP) (OTCQB: TBPMF) Accelerates its Cannabis-based Clinical Research Program in the Veterinary Market

Tetra Bio-Pharma (TSX.V: TBP) (OTCQB: TBPMF), a biopharmaceutical leader in cannabinoid-based drug discovery and development, is adding international expert Dr. Louis-Philippe de Lorimier, a board certified veterinary oncologist, to its clinical advisory board for the veterinary market. In a news release, Dr. Guy Chamberland, chief scientific officer of Tetra Bio-Pharma, said, "We are leveraging our current R&D work in humans to accelerate the development of the first cannabinoid-based drug for pets in the cancer-associated supportive therapy market, including pain. This market is underserved and patients and their owner are waiting for alternatives that are safer, more tolerable and more efficacious.”…

MondaySep 11, 2017 12:20 pm

CannabisNewsBreaks – Terra Tech Corp. (TRTC) Files Provisional Patent Application for Cannabis-Infused Rolling Papers

Terra Tech Corp. (OTCQX: TRTC), a vertically integrated, cannabis-focused agriculture company, has filed a patent application with the U.S. Patent and Trademark Office for innovative cannabis-infused rolling papers. Expected to launch in 2018, the inventive rolling papers will be the latest addition to the company’s portfolio of IVXX™ branded premium cannabis products, which includes flowers, concentrates, custom-rolled joints and edibles. As with all its products, the rolling papers will be free of toxic pesticides, harmful molds and chemical residues, the company states. In the news release, Derek Peterson, CEO of Terra Tech, said, “Infusing rolling papers with cannabis can enhance…

MondaySep 11, 2017 10:05 am

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Retains Biopsy, LLC to Provide Leadership in Growth and E-Commerce

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its retention of Biopsy, LLC, managed by bestselling author Chris J. Snook, to provide leadership in growth and e-commerce. Effective September 1, 2017, Biopsy, LLC will serve as the architect of the digital infrastructure and go-to-market strategy for ChineseInvestors.com, Inc. and its subsidiaries, reporting directly to the companies’ management teams. “ChineseInvestors.com, Inc. is fortunate to be able to contract with Biopsy, LLC as Chris' unique skill and experience will enhance the Company's ability to effectively emerge as a leader in the CBD Biotechnology Industry, while also strengthening and expanding the…

MondaySep 11, 2017 9:11 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Provides Update on Data Linking THC to Decrease in Aβ40 Protein Production

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced compelling in vitro data compiled from genetically engineered cell lines showing that, at varying concentrations of THC, the production of Aβ40 protein decreases by as much as 50 percent over a 48-hour period. This is particularly noteworthy for patients with Alzheimer’s disease, as the condition often results in an imbalance of Aβ plaque that is believed to be toxic to nerve cells. This data, compiled by Dr. Chuanhai Cao, an IGC senior advisor and associate professor of pharmaceutical…

FridaySep 08, 2017 9:14 am

CannabisNewsBreaks – Leafbuyer Technologies (LBUY) Enters Deal with Leading Dispensary Chain

Leafbuyer Technologies, Inc. (OTC: LBUY), a leading cannabis technology platform known as the premier cannabis deals network, is adding Rocky Road Remedies to its client base. Leafbuyer will provide a suite of services to Rocky Road Remedies, a leading cannabis dispensary chain with six locations in Colorado. Leafbuyer drives business to dispensaries and product clients through its online platform, Leafbuyer.com In the news release, Leafbuyer vice president of business development and co-founder Mark Breen said, “We are committed to driving business to our customer base as well as providing the best deals for the consumer in the cannabis industry.” To…

ThursdaySep 07, 2017 1:09 pm

CannabisNewsBreaks – Organigram (TSX.V: OGI) (OTCQB: OGRMF) Enters into MOU for Microwave Assisted Extraction Technique Development

Organigram Holdings Inc. (TSX.V: OGI) (OTCQB: OGRMF) will jointly develop an industry leading method of microwave extraction of cannabinoid extracts from marijuana plants with the New Brunswick Innovation Research Chair in Medical Technologies (NBIRC), an initiative of the New Brunswick Innovation Fund (NBIF), it was announced Wednesday. A memorandum of understanding between Organigram Holdings Inc. and NBIRC details the project which will focus on developing a more efficient manner of extracting cannabinoids for use in extracts and edibles. The project will be led by Dr. J. R. Jocelyn Paré, holder of the NBIRC, the inventor of various Microwave-Assisted Processes forming…

ThursdaySep 07, 2017 1:02 pm

CannabisNewsBreaks – Cannabics Pharmaceuticals (CNBX) Files Patent Application for Sensitivity Tests of Cannabinoids on Patient Derived Tumor Biopsies and CTCs

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) has filed an extensive provisional patent application with the U.S. Patent & Trademark Office on a new “Method for Sensitivity Tests of Cannabinoids on Patient Derived Tumor Biopsies and CTCs.” The method, developed by Cannabics Pharmaceuticals, expands the company’s proprietary technology of personalization of cannabinoid medicine. The current invention pertains to a combined method and system for assessing the sensitivity of a variety of cannabinoid-based treatment modalities on patient-derived primary tumor biopsies as well as blood circulating tumor cells (CTC). In the news release, Dr. Moran Grinberg, Cannabics Pharmaceuticals Vice President of Research and Development,…

News and publishing service for cannabis related companies

Contact us: 303.498.7722

CannabisNewsBreaks